How ICON Transformed Its Clinical Trial Processes with RPA
To bring a new drug to market, it can cost over $2B. Many industry experts see a need to transform the way clinical trials are conceived, designed and conducted to battle declining ROI. The solution: RPA.
As one of the world’s largest Contract Research Organizations—handling every aspect of the drug and device development process for pharmaceutical and medical device clients—ICON plc has been introducing digital automation into the drug development process for several years to increase efficiency and reduce time and costs.